About Us

We are a multi-disciplinary team of pathologists, biologists, analysts, software engineers, and technicians who are committed to creating successful approaches which match patients with life-saving drugs.

Helping Biomedical Companies
Change Lives.

Flagship leverages contextual tissue biomarkers to accelerate drug development
with confident, data-driven decisions.

Download Flagship Facts 2019

Key Facts:

  • Largest clinical digital immunohistochemistry (IHC) operation in the world
  • Exclusively serving pharma and biotech with our patented technology
  • Integrated scientific team delivers optimal data for decision making
  • Technology for quantitative and comprehensive data in tissue context
  • Clinically implemented technology in a scalable, efficient operation
  • Over 500 projects completed for over 100 clients since 2009
Our Facilities

Our experts are focused on delivering your success in our integrated wet assay and image analysis laboratories.

State of the art histology laboratory

State of the art histology laboratory

Advanced digital immunohistochemistry laboratory

Advanced digital immunohistochemistry laboratory

High-throughput digital immunohistochemistry analysis capabilities

High-throughput digital immunohistochemistry analysis capabilities

Brightfield and fluorescent whole slide scanning

Brightfield and fluorescent whole slide scanning

Flexibility on multiple platforms

Flexibility on multiple platforms

CAP accredited & CLIA certified laboratory

CAP accredited & CLIA certified laboratory

Pathology AI Platform for IO

Professional Organizations

We are involved and contribute to the advancement of our field through professional participation.

Over 100 pharmaceutical, biotech, and medical device firms rely on Flagship's technology for success.

Our combination of biology, pathology, and technology has advanced emerging therapies in over 400 studies.